+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Human Embryonic Stem Cell (hESC) Research: Global Strategic Business Report

  • PDF Icon

    Report

  • 184 Pages
  • December 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 2228035

Quick Summary:

In the fast-evolving biomedical world, Human Embryonic Stem Cell (hESC) Research is a rapidly growing industry with profound implications for regenerative medicine. This expanding market is predicted to reach $1.3 billion by 2030, from $757.4 million in 2022. With the rise of regenerative treatments, the significance of such research holds immense potential for groundbreaking discoveries and advanced therapy options.

Within this valuable market research report, readers will gain a comprehensive understanding of the industry outlook and key players, while benchmarking their strategies against top competitors. With the assurance of complimentary updates for one year, the report guarantees up-to-date market insights to keep your business ahead of the curve. Additionally, it provides access to digital archives and a research platform, along with special interaction opportunities to facilitate growth. The opportunity to secure a strategically competitive edge in hESC Research awaits with this all-inclusive report.

Global Human Embryonic Stem Cell (hESC) Research Market to Reach $1.3 Billion by 2030

The global market for Human Embryonic Stem Cell (hESC) Research estimated at US$757.4 Million in the year 2022, is projected to reach a revised size of US$1.3 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2022-2030. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$892.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $221.6 Million, While China is Forecast to Grow at 6.1% CAGR

The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$221.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$219.3 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.

Select Competitors (Total 24 Featured) -

  • Astellas Institute of Regenerative Medicine
  • Asterias Biotherapeutics, Inc.
  • BD Biosciences
  • Cell Cure Neurosciences Ltd.
  • Cellular Dynamics International
  • GE Healthcare
  • PerkinElmer, Inc.
  • Reliance Life Sciences Ltd.
  • Research & Diagnostics Systems, Inc.
  • STEMCELL Technologies, Inc.
  • Stemina Biomarker Discovery, Inc.
  • Takara Bio, Inc.
  • TATAA Biocenter AB
  • Thermo Fischer Scientific Inc.
  • UK Stem Cell Bank
  • ViaCyte, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Human Embryonic Stem Cell (hESC) Research

What is the estimated value of the Global Market for Human Embryonic Stem Cell (hESC) Research?

The Global Market for Human Embryonic Stem Cell (hESC) Research was estimated to be valued at $757.4 Million in 2022.

What is the growth rate of the Global Market for Human Embryonic Stem Cell (hESC) Research?

The growth rate of the Global Market for Human Embryonic Stem Cell (hESC) Research is 7.0%, with an estimated value of $1300 Million by 2030.

What is the forecasted size of the Global Market for Human Embryonic Stem Cell (hESC) Research?

The Global Market for Human Embryonic Stem Cell (hESC) Research is estimated to be worth $1300 Million by 2030.

Who are the key companies in the Global Market for Human Embryonic Stem Cell (hESC) Research?

Key companies in the Global Market for Human Embryonic Stem Cell (hESC) Research include Astellas Institute of Regenerative Medicine, Asterias Biotherapeutics, Inc., BD Biosciences, Cell Cure Neurosciences Ltd., Cellular Dynamics International, GE Healthcare, PerkinElmer, Inc., Reliance Life Sciences Ltd., Research & Diagnostics Systems, Inc. and STEMCELL Technologies, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Stem Cells Research: A Sunrise Sector in Biotechnology Arena
  • Human Embryonic Stem Cells - An Introduction
  • Embryonic Stem Cells - Sources and Cell Culture
  • Comparison on Adult and Embryonic Stem Cells
  • Advantages and Drawbacks of Various Stem Cells
  • Recent Market Activity
  • Human Embryonic Stem Cells - The Market Perspective
  • Timeline for Embryonic Stem Cell Research Activities: Major Events from 1963 through 2014
  • Teratomas - No Longer an Impediment to Stem Cell Therapy Development
  • Human Embryonic and Induced Pluripotent Stem Cell Research Trends
  • Human Embryonic Stem Cell Research: Key Statistical Highlights
  • Research Topics on hESC and hiPSC by Number of Papers Published: 2011-2013
  • Haploid Human Embryonic Stem Cell Line: The New Frontier
  • Human Induced Pluripotent Stem Cells Remains Best Alternative for hESC
  • Human Embryonic Stem Cell (hESC) Research - Global Key Competitors Percentage Market Share in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
  • Astellas Institute of Regenerative Medicine (US)
  • Asterias Biotherapeutics, Inc. (US)
  • BD Biosciences (US)
  • Cell Cure Neurosciences Ltd. (Israel)
  • Cellular Dynamics International (US)
  • GE Healthcare (UK)
  • MilliporeSigma (US)
  • PerkinElmer, Inc. (US)
  • Reliance Life Sciences Ltd. (India)
  • Research & Diagnostics Systems, Inc. (US)
  • SABiosciences Corp. (US)
  • STEMCELL Technologies, Inc. (Canada)
  • Stemina Biomarker Discovery, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • TATAA Biocenter AB (Sweden)
  • Thermo Fisher Scientific, Inc. (US)
  • UK Stem Cell Bank (UK)
  • ViaCyte, Inc. (US)
  • Vitrolife AB (Sweden)
3. MARKET TRENDS & DRIVERS
  • Issues Hindering Development of hESC Research
  • Consideration of Best Translational Pathways Pivotal in Ensuring Growth Of hESCs
  • Ethical Issues and Technical Hurdles Bog Down hESC Research
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Stem Cell Biology Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Stem Cell Biology Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 11: World Human Embryonic Stem Cell (hESC) Research Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 12: USA Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 13: USA 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
CANADA
  • Table 14: Canada Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 15: Canada 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
JAPAN
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 16: Japan Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 17: Japan 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
CHINA
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 18: China Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 19: China 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
EUROPE
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 20: Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 21: Europe 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 22: Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 23: Europe 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
FRANCE
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 24: France Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 25: France 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
GERMANY
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 26: Germany Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: Germany 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
ITALY
  • Table 28: Italy Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 29: Italy 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
UNITED KINGDOM
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 30: UK Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 31: UK 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
REST OF EUROPE
  • Table 32: Rest of Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Rest of Europe 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
ASIA-PACIFIC
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 34: Asia-Pacific Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 35: Asia-Pacific 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
REST OF WORLD
  • Table 36: Rest of World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 37: Rest of World 8-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Astellas Institute of Regenerative Medicine
  • Asterias Biotherapeutics, Inc.
  • BD Biosciences
  • Cell Cure Neurosciences Ltd.
  • Cellular Dynamics International
  • GE Healthcare
  • PerkinElmer, Inc.
  • Reliance Life Sciences Ltd.
  • Research & Diagnostics Systems, Inc.
  • STEMCELL Technologies, Inc.
  • Stemina Biomarker Discovery, Inc.
  • Takara Bio, Inc.
  • TATAA Biocenter AB
  • Thermo Fischer Scientific Inc.
  • UK Stem Cell Bank
  • ViaCyte, Inc.